First Wave of COVID-19 in French Patients with Cystic Fibrosis.
COVID-19
Cystic Fibrosis
SARS-CoV-2
acute respiratory distress syndrome
lung transplant
Journal
Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588
Informations de publication
Date de publication:
10 Nov 2020
10 Nov 2020
Historique:
received:
07
10
2020
revised:
27
10
2020
accepted:
09
11
2020
entrez:
13
11
2020
pubmed:
14
11
2020
medline:
14
11
2020
Statut:
epublish
Résumé
Viral infections are known to lead to serious respiratory complications in cystic fibrosis (CF) patients. Hypothesizing that CF patients were a population at high risk for severe respiratory complications from SARS-CoV-2 infection, we conducted a national study to describe the clinical expression of COVID-19 in French CF patients. This prospective observational study involves all 47 French CF centers caring for approximately 7500 CF patients. Between March 1st and June 30th 2020, 31 patients were diagnosed with COVID-19: 19 had positive SARS-CoV-2 RT-PCR in nasopharyngeal swabs; 1 had negative RT-PCR but typical COVID-19 signs on a CT scan; and 11 had positive SARS-CoV-2 serology. Fifteen were males, median (range) age was 31 (9-60) years, and 12 patients were living with a lung transplant. The majority of the patients had CF-related diabetes (
Identifiants
pubmed: 33182847
pii: jcm9113624
doi: 10.3390/jcm9113624
pmc: PMC7697588
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : Association Vaincre La Mucoviscidose and Filière de Santé Maladies rares Muco-CFTR
ID : Not appopriate
Références
Genes Immun. 2020 Aug;21(4):260-262
pubmed: 32606316
BMC Infect Dis. 2016 Feb 01;16:55
pubmed: 26830335
Pediatr Radiol. 2020 Sep;50(10):1354-1368
pubmed: 32749530
Science. 2020 Jul 10;369(6500):208-211
pubmed: 32404476
J Cyst Fibros. 2011 Sep;10(5):370-6
pubmed: 21752728
J Virol. 2016 Apr 14;90(9):4258-4261
pubmed: 26865718
J Cyst Fibros. 2020 May;19(3):355-358
pubmed: 32376098
Science. 2020 Mar 27;367(6485):1444-1448
pubmed: 32132184
Cell. 2018 Jan 11;172(1-2):147-161.e12
pubmed: 29328910
J Korean Med Sci. 2020 Jun 08;35(22):e204
pubmed: 32508068
J Microbiol Immunol Infect. 2020 May 15;:
pubmed: 32425996
Science. 1989 Sep 8;245(4922):1066-73
pubmed: 2475911
Lancet. 2020 May 9;395(10235):1481
pubmed: 32353326
Emerg Microbes Infect. 2020 Dec;9(1):1175-1179
pubmed: 32448084
Chest. 2013 Mar;143(3):782-790
pubmed: 23188200
Clin Chim Acta. 2020 Jun;505:172-175
pubmed: 32156607
J Cyst Fibros. 2005 Aug;4 Suppl 2:31-6
pubmed: 15964785
Radiology. 2020 Aug;296(2):E79-E85
pubmed: 32243238
Lancet. 2016 Nov 19;388(10059):2519-2531
pubmed: 27140670
J Clin Med. 2020 May 18;9(5):
pubmed: 32443459
Trends Immunol. 2013 Sep;34(9):431-9
pubmed: 23680130
Eur Respir J. 2015 Feb;45(2):428-39
pubmed: 25359346
Respir Med. 2020 Aug - Sep;170:106062
pubmed: 32843180
Proc Natl Acad Sci U S A. 2020 Mar 31;117(13):7001-7003
pubmed: 32165541
Thorax. 2006 Jul;61(7):641-2
pubmed: 16807394
Clin Infect Dis. 2017 Jun 15;64(12):1760-1767
pubmed: 28329304
Vaccine. 2014 Jul 31;32(35):4515-21
pubmed: 24950362
Front Immunol. 2018 Dec 20;9:3067
pubmed: 30619379
Lancet Respir Med. 2020 May;8(5):e35-e36
pubmed: 32304639
Lancet Respir Med. 2020 Jan;8(1):65-124
pubmed: 31570318
Cell Host Microbe. 2011 May 19;9(5):355-61
pubmed: 21575907
Front Pharmacol. 2020 Jul 23;11:1096
pubmed: 32848733
Antiviral Res. 2020 Apr;176:104742
pubmed: 32057769
J Clin Med. 2020 Aug 30;9(9):
pubmed: 32872629
Pediatr Infect Dis J. 2020 May;39(5):355-368
pubmed: 32310621
J Cyst Fibros. 2016 Mar;15(2):204-12
pubmed: 26391389
Ther Clin Risk Manag. 2020 Jul 03;16:617-629
pubmed: 32694915
Ann Am Thorac Soc. 2015 Nov;12 Suppl 2:S200-6
pubmed: 26595740
Transl Res. 2016 Feb;168:40-49
pubmed: 25940043
Int J Antimicrob Agents. 2020 Jul;56(1):105949
pubmed: 32205204
J Clin Med. 2020 Sep 12;9(9):
pubmed: 32932612
Cleve Clin J Med. 2020 May 5;:
pubmed: 32371562